View in EDS

Phase 2 Trial of Long-Acting Cabotegravir and VRC07-523LS for Viral Suppression in Adults With HIV-1: ACTG A5357.

Saved in:
Bibliographic Details
Title: Phase 2 Trial of Long-Acting Cabotegravir and VRC07-523LS for Viral Suppression in Adults With HIV-1: ACTG A5357.
Authors: Taiwo BO; Division of Infectious Diseases, Department of Medicine, Northwestern University, Chicago, Illinois, USA., Zheng Y; ACTG Statistical and Data Analysis Center (SDAC), Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA., Rodriguez K; ACTG Statistical and Data Analysis Center (SDAC), Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA., Burke L; Department of Medicine, Yale New Haven Health, New Haven, Connecticut, USA., Reeves JD; Labcorp-Monogram Biosciences, San Francisco, California, USA., Scarsi KK; College of Pharmacy, University of Nebraska Medical Center, Omaha, Nebraska, USA., Gama L; Vaccine Research Center, National Institutes of Health, Bethesda, Maryland, USA., Petropoulos CJ; Labcorp-Monogram Biosciences, San Francisco, California, USA., Belaunzaran-Zamudio PF; Contractor for Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Wannamaker P; ViiV Healthcare, Durham, North Carolina, USA., D'Amico R; ViiV Healthcare, Durham, North Carolina, USA., Rathod P; DLH Corporation, Bethesda, Maryland, USA., Bar KJ; Division of Infectious Diseases, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Tebas P; Division of Infectious Diseases, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Corporate Authors: A5357 Study Team
Source: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2026 Feb 09; Vol. 82 (1), pp. 100-108.
Publication Type: Journal Article; Clinical Trial, Phase II; Multicenter Study
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40663628
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Phase 2 Trial of Long-Acting Cabotegravir and VRC07-523LS for Viral Suppression in Adults With HIV-1: ACTG A5357.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Taiwo+BO%22">Taiwo BO</searchLink>; Division of Infectious Diseases, Department of Medicine, Northwestern University, Chicago, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Zheng+Y%22">Zheng Y</searchLink>; ACTG Statistical and Data Analysis Center (SDAC), Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Rodriguez+K%22">Rodriguez K</searchLink>; ACTG Statistical and Data Analysis Center (SDAC), Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Burke+L%22">Burke L</searchLink>; Department of Medicine, Yale New Haven Health, New Haven, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Reeves+JD%22">Reeves JD</searchLink>; Labcorp-Monogram Biosciences, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Scarsi+KK%22">Scarsi KK</searchLink>; College of Pharmacy, University of Nebraska Medical Center, Omaha, Nebraska, USA.<br /><searchLink fieldCode="AU" term="%22Gama+L%22">Gama L</searchLink>; Vaccine Research Center, National Institutes of Health, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Petropoulos+CJ%22">Petropoulos CJ</searchLink>; Labcorp-Monogram Biosciences, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Belaunzaran-Zamudio+PF%22">Belaunzaran-Zamudio PF</searchLink>; Contractor for Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Wannamaker+P%22">Wannamaker P</searchLink>; ViiV Healthcare, Durham, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22D'Amico+R%22">D'Amico R</searchLink>; ViiV Healthcare, Durham, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Rathod+P%22">Rathod P</searchLink>; DLH Corporation, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Bar+KJ%22">Bar KJ</searchLink>; Division of Infectious Diseases, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Tebas+P%22">Tebas P</searchLink>; Division of Infectious Diseases, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22A5357+Study+Team%22">A5357 Study Team</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229203213%22">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</searchLink> [Clin Infect Dis] 2026 Feb 09; Vol. 82 (1), pp. 100-108.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase II; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9203213 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1537-6591 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210584838%22">10584838 </searchLink><i>NLM ISO Abbreviation: </i>Clin Infect Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40663628
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/cid/ciaf375
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 100
    Titles:
      – TitleFull: Phase 2 Trial of Long-Acting Cabotegravir and VRC07-523LS for Viral Suppression in Adults With HIV-1: ACTG A5357.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Taiwo BO
      – PersonEntity:
          Name:
            NameFull: Zheng Y
      – PersonEntity:
          Name:
            NameFull: Rodriguez K
      – PersonEntity:
          Name:
            NameFull: Burke L
      – PersonEntity:
          Name:
            NameFull: Reeves JD
      – PersonEntity:
          Name:
            NameFull: Scarsi KK
      – PersonEntity:
          Name:
            NameFull: Gama L
      – PersonEntity:
          Name:
            NameFull: Petropoulos CJ
      – PersonEntity:
          Name:
            NameFull: Belaunzaran-Zamudio PF
      – PersonEntity:
          Name:
            NameFull: Wannamaker P
      – PersonEntity:
          Name:
            NameFull: D'Amico R
      – PersonEntity:
          Name:
            NameFull: Rathod P
      – PersonEntity:
          Name:
            NameFull: Bar KJ
      – PersonEntity:
          Name:
            NameFull: Tebas P
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 09
              M: 02
              Text: 2026 Feb 09
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1537-6591
          Numbering:
            – Type: volume
              Value: 82
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
              Type: main
ResultId 1